Stay updated on Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page.

Latest updates to the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a Locations section listing Florida as a participating site, removed the separate Florida Locations entry and the HHS Vulnerability Disclosure link, and updated the page revision to v3.3.3.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedPubMed publications description updated from a manual statement to an automatically filled description, and the revision label updated to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedThe notice about government funding and operating status is removed from the page.SummaryDifference0.4%

- Check63 days agoChange DetectedThe screenshot shows the same study record with minor layout adjustments and an updated last updated timestamp; there are no changes to the study details or eligibility criteria.SummaryDifference0.4%

- Check91 days agoChange DetectedCore content updated with a government-operating status notice and a version bump to v3.2.0; a specific resource entry (Small cell lung carcinoma) and the old version tag v3.1.0 were removed.SummaryDifference3%

- Check99 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Nivolumab w/Thoracic Radiotherapy Clinical Trial page.